Additional file 1 of Real-world comparative effectiveness and safety of tofacitinib and baricitinib in patients with rheumatoid arthritis

Iwamoto, Naoki; Sato, Shuntaro; Kurushima, Shota; Michitsuji, Toru; Nishihata, Shinya; Okamoto, Momoko; Tsuji, Yoshika; Endo, Yushiro; Shimizu, Toshimasa; Sumiyoshi, Remi; Suzuki, Takahisa; Okada, Akitomo; Koga, Tomohiro; Kawashiri, Shin-ya; Fujikawa, Keita; Igawa, Takashi; Aramaki, Toshiyuki; Ichinose, Kunihiro; Tamai, Mami; Nakamura, Hideki; Mizokami, Akinari; Origuchi, Tomoki; Ueki, Yukitaka; Eguchi, Katsumi; Kawakami, Atsushi

doi:10.6084/m9.figshare.15047635.v1

13075_2021_2582_MOESM1_ESM.docx (16.61 kB)

Additional file 1 of Real-world comparative effectiveness and safety of tofacitinib and baricitinib in patients with rheumatoid arthritis

journal contribution

posted on 2021-07-24, 04:04 authored by Naoki Iwamoto, Shuntaro Sato, Shota Kurushima, Toru Michitsuji, Shinya Nishihata, Momoko Okamoto, Yoshika Tsuji, Yushiro Endo, Toshimasa Shimizu, Remi Sumiyoshi, Takahisa Suzuki, Akitomo Okada, Tomohiro Koga, Shin-ya Kawashiri, Keita Fujikawa, Takashi Igawa, Toshiyuki Aramaki, Kunihiro Ichinose, Mami Tamai, Hideki Nakamura, Akinari Mizokami, Tomoki Origuchi, Yukitaka Ueki, Katsumi Eguchi, Atsushi Kawakami

Additional file 1: Supplementary Table S1. Comparison of baseline characteristics in patients with different backgrounds.